- Question from Marium: What was the most important information discussed for bone metastasis-only metastatic patients?
- Answers - Eric Winer, M.D. I don't know that there was anything terribly new about metastasis. The news has been development of the drug denosumab (brand name: Prolia), which like the drug Zometa (chemical name: zoledronic acid) can decrease complications from bone metastasis in women with advanced breast cancer.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.